Karin JoossEVP, Head of R&D at Gritstone BioSpeaker
Agenda Sessions
Targeting Advanced Metastatic Solid Tumors With Self-Amplifying Neoantigen Vaccines
, 2:15pmView Session
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Targeting Advanced Metastatic Solid Tumors With Self-Amplifying Neoantigen Vaccines